IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report

By Martinez-Redondo C.   Ortuño F.   Lozano M.   Jerez A.   del Mar Osma M.   Giraldo P.   Vicente V.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 265-267

Springer Publishing Company

Access to resources Recommend Favorite

A neurological symptom survey of patients with type I Gaucher disease

By Pastores G. M.   Pastores G. M.   Barnett N. L.   Bathan P.   Kolodny E. H.  

Journal of Inherited Metabolic Disease, Vol. 26, Iss. 7, 2003-01 ,pp. : 641-645

Springer Publishing Company

Access to resources Recommend Favorite

The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)

By Chérin P.   Rose C.   Roux-Serratrice C.   Tardy D.   Dobbelaere D.   Grosbois B.   Hachulla E.   Jaussaud R.   Javier R.-M.   Noël E.   Clerson P.   Hartmann A.  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 4, 2010-08 ,pp. : 331-338

Springer Publishing Company

Access to resources Recommend Favorite

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa

By Wendt S.   Whybra C.   Kampmann C.   Teichmann E.   Beck M.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 5, 2005-09 ,pp. : 787-788

Springer Publishing Company

Access to resources Recommend Favorite

TYPE I GAUCHER DISEASE IN CHILDREN WITH AND WITHOUT ENZYME THERAPY

By Dweck Altoon   Abrahamov Ayala   Hadas-Halpern Irith   Bdolach-Avram Tali   Zimran Ari   Elstein Deborah  

Pediatric Hematology and Oncology, Vol. 19, Iss. 6, 2002-09 ,pp. : 389-397

Informa Healthcare

Access to resources Recommend Favorite